SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Raises PTC Therapeutics Price Target to $77 From $75

RBC raised its price target on PTC Therapeutics to $77 from $75 and kept its Sector Perform rating.

PTCT

Related stories